R. Mark Adams - 17 Jun 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Operating Officer
Signature
/s/ R Mark Adams by Eric L. Billings, attorney-in-fact
Issuer symbol
ADPT
Transactions as of
17 Jun 2021
Net transactions value
-$173,538
Form type
4
Filing time
21 Jun 2021, 20:00:47 UTC
Previous filing
16 Jun 2021
Next filing
08 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $409,782 +14,583 +25% $28.10 72,687 17 Jun 2021 Direct F1
transaction ADPT Common Stock Sale $583,320 -14,583 -20% $40.00* 58,104 17 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -14,583 -29% $0.000000 35,417 17 Jun 2021 Common Stock 14,583 $28.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.
F2 The options vest with respect to 1/4 of such shares on April 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.